Pregabalin-induced liver injury – Case report
نویسندگان
چکیده
منابع مشابه
Albendazole-induced liver injury: a case report
We report a case of a 47-year-old male, who was referred to the clinical hepatology services at Pablo Tobón Uribe Hospital for evaluation of a jaundice syndrome. After undergoing several exams, we diagnosed hepatic hydatidosis and the patient was treated with albendazole; however, after five months of uninterrupted treatment the patient again consulted and his liver test showed marked hepatocel...
متن کاملDrug-induced liver injury due to varenicline: a case report
BACKGROUND Liver injury due to prescription and nonprescription medications is an expanding public health concern in the United States, with drug-induced liver injury (DILI) being the single most common reason for regulatory actions instituted by the Food and Drug Administration against certain medications and supplements. CASE PRESENTATION A 69-year-old Latino man was referred to Hepatology ...
متن کاملPregabalin Dependence : A Case Report 2
Pregabalin is a new generation antiepileptic that exerts its effect by decreasing the release of such neurotransmitters as glutamate, noradrenaline, and substance P. Pregabalin can be prescribed in Turkey at 150-600 mg to treat neuropathic pain, generalized anxiety disorder, fibromyalgia, and as concomitant therapy in adult patients with partial epilepsy. Experimental studies have shown that pr...
متن کاملDrug-Induced Liver Injury Caused by Adalimumab: A Case Report and Review of the Bibliography
The most serious adverse drug reaction of adalimumab (ADR) is tuberculosis reactivation. We describe a case of a 35-year-old man, with rheumatoid arthritis (RA) and hepatitis C virus genotype 1a with a liver biopsy in 2001 with a METAVIR score pattern A1 F0; he received interferon alpha 2b for six months, but treatment was suspended because of reactivation of RA. Liver function tests after trea...
متن کاملHepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.
The United States Food and Drug Administration recently warned that the direct acting antiviral (DAA) combination hepatitis C virus (HCV) treatment of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin (PODr + R) can cause severe liver injury in patients with advanced liver disease. Drug induced liver injury was observed in a small number of patients with decompensated cirrhosis trea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Colombian Journal of Anesthesiology
سال: 2017
ISSN: 2256-2087
DOI: 10.1016/j.rcae.2017.08.005